Form 4: Bioventus Inc. Executive Exercises Stock Options
SEC Form 4 Filing
Anthony D'Adamio, SVP & General Counsel of Bioventus Inc., reports the vesting and conversion of restricted stock units into Class A Common Stock.
Summary
- On March 14, 2025, Anthony D'Adamio, SVP & General Counsel of Bioventus Inc., exercised 8,886 restricted stock units (RSUs).
- These RSUs converted into 8,886 shares of Class A Common Stock.
- Following the transaction, D'Adamio directly owns 127,064 shares of Class A Common Stock and 8,886 RSUs.
- The RSUs were part of an original grant of 35,545 RSUs that vest in four approximately equal annual installments beginning on March 14, 2023.
Sentiment
Score: 5
Explanation: This is a routine transaction related to executive compensation. It's neither particularly positive nor negative.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This filing indicates the vesting of previously granted compensation.
Stakeholder Impact
- The transaction increases the number of outstanding shares of Class A Common Stock, potentially diluting existing shareholders' equity slightly.
Key Dates
| Date | Description |
|---|---|
| 03/14/2023 | Start date of the four approximately equal annual installments for vesting of 35,545 RSUs. |
| 03/14/2025 | Date of transaction: Exercise of 8,886 Restricted Stock Units (RSUs) and conversion to Class A Common Stock. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.